Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Conflict of interest Author AA has received consulting fees from AbbVie, Allergan, Amgen, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz and Takeda
The European Medicines Agency reached a similar conclusion in 2024, confirming that while a connection could not be proven, continued vigilance was warranted
Risk of Thyroid C-cell Tumors The GLP-1RAs exenatide extended-release, liraglutide, dulaglutide, and injectable and oral semaglutide have a boxed warning for thyroid C-cell tumors (observed in preclinical studies with rodents) 4,19-22
This hormone helps regulate blood sugar and appetite
